Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 3/20 | 0.46 |
| ▸ | TACR1 | P25103 | 12/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.42 |
| ▸ | FPR1 | P21462 | 1/20 | 0.41 |
| ▸ | FPR2 | P25090 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1968280 | 1.00 | RORC (0.46) | RORCTACR1PDE4BFPR1FPR2 | |
| SCHEMBL30693163 | 0.95 | TACR1 (0.49) | RORCTACR1PDE4BFPR1FPR2 | |
| SCHEMBL1970588 | 0.95 | TACR1 (0.49) | RORCTACR1PDE4BFPR1FPR2 | |
| SCHEMBL30693160 | 0.95 | TACR1 (0.49) | RORCTACR1PDE4BFPR1FPR2 | |
| SCHEMBL1968872 | 0.95 | TACR1 (0.49) | RORCTACR1PDE4BFPR1FPR2 | |
| SCHEMBL1972466 | 0.95 | TACR1 (0.49) | RORCTACR1PDE4BFPR1FPR2 | |
| SCHEMBL1966861 | 0.90 | RORC (0.45) | RORCTACR1PDE4BFPR1FPR2 | |
| SCHEMBL1968060 | 0.90 | RORC (0.45) | RORCTACR1PDE4BFPR1FPR2 | |
| SCHEMBL15397487 | 0.88 | TACR1 (0.43) | TACR1FPR1FPR2KDR | |
| SCHEMBL1968672 | 0.87 | TACR1 (0.49) | RORCTACR1FPR1FPR2HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE49686-E1 | Nitrogen-containing heterocyclic compound and use of same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-10-10 | — | — | US | disclosed |